Upregulation of FGL1 facilitates tumour progression and metastasis in liver cancer, non‐small‐cell lung cancer and esophageal squamous cell carcinoma.44, 45, 46, 47. Here, FGL1 is linked to esophageal squamous cell carcinoma.